SuperworthWhitehawk Therapeutics market cap WHWK
Share price times shares outstanding: what the whole company sells for, since 2017.
- Today, Oct 23, 2026
- $183M
- Highest close in our data
- $79.2B
- Sep 2017
Whitehawk Therapeutics is worth $183M at the close on Oct 23, 2026, at $3.21 a share.
That is up 61% over the last year and down 100% over five years.
Its highest close in our data was $79.2B in Sep 2017.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $183M | $115M | $271.4M | +45% |
| 2025 | $125.8M | $48.8M | $125.8M | +59% |
| 2024 | $79.1M | $32.7M | $83.6M | +60% |
| 2023 | $49.5M | $48.3M | $315.9M | −84% |
| 2022 | $313M | $254.7M | $512.1M | −38% |
| 2021 | $504.6M | $403.7M | $53.3B | −98% |
| 2020 | $20.8B | $8.4B | $47.7B | +96% |
| 2019 | $10.6B | $8.4B | $77.6B | −66% |
| 2018 | $31.2B | $31.2B | $71.2B | −46% |
| 2017 | $57.9B | $48.7B | $79.2B | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Whitehawk Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| WHWKWhitehawk Therapeutics | $183M |
| NATRNatures Sunshine Products | $213.8M |
| LFVNLifevantage | $73.4M |
| ARVNArvinas | $477.3M |
| SPROSpero Therapeutics | $64.6M |
| PBYIPuma Biotechnology | $568.9M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| ZVRAZevra Therapeutics | $582.6M |
| CRMDCorMedix | $611.9M |
| ATNMActinium Pharmaceuticals | $47.8M |
| COLLCollegium Pharmaceutical | $747.5M |
| Peer median | $523.1M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Whitehawk Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.